April 14 (Reuters) - VOGO SAS ALVGO.PA :
* COVID-19 - VOGO PARTICIPATION IN DEVELOPMENT, PRODUCTION
AND
DISTRIBUTION OF A RAPID SALIVA-BASED SCREENING TEST
* ANNOUNCES THAT IT IS COLLABORATING WITH SCIENTISTS FROM
CNRS
(FRENCH NATIONAL CENTER FOR SCIENTIFIC RESEARCH) LABORATORY
SYS2DIAG, AND WITH BIOTECHNOLOGY COMPANY SKILLCELL FOR PROVIDING
RAPID SALIVA-BASED SCREENING TEST, IF RESULTS OF THE CLINICAL
TRIAL ARE CONCLUSIVE
* VOGO HAS ALREADY BEGUN DEVELOPING THE TECHNOLOGICAL TOOL
(A
SMARTPHONE APP) THAT WILL PROVIDE THIS AUTOMATION
Source text: https://bit.ly/3cdu30E
Further company coverage: ALVGO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))